Menarini opens new regional headquarters in Dubai, United Arab Emirates | News

The pharmaceutical group, represented in 140 countries around the world, wants to raise the standard of medical care for patients in the Middle East and Africa (MEA) thanks to innovative products and groundbreaking research results

DUBAIUAE, May 27, 2022 / PRNewswire / – Menarini, a leading Italian pharmaceutical company founded in 1886, today opened its regional headquarters in Dubai Science Park as part of its goal of expanding its presence in the Middle East and Africa (MEA) region. The group, which specializes in pharmaceutical research and production, consumer health, oncology and diagnostics, is setting up a new regional office in Menarini in the Middle East and Africa in Dubai as it is an ideal location to promote the health and well-being of patients in the region and establish important contacts with key industry stakeholders.

Influential dignitaries of the health service, above all, took part in the inaugurationSE. dr Amin Hussain Al AmiriUndersecretary of State for Health Policy and Licensing of the UAE Ministry of Health and Prevention;SE Nicola LenerThe Italian ambassador to the United Arab Emirates, as well as the management staff of the global Menarini team, incl.Dr. Luca LastrucciGroup CEO,dr Ugur Bingolpresident of META iDr. Basel Thaherregional director for the Middle East and general manager of MEA.

Elcin Barker Ergungeneral manager Menarini group and board member said::Today is a historic moment for us when we open our regional offices in Dubai, an important turning point for the significant expansion of our presence and portfolio in the Middle East. As a 135-year-old family business, we look forward to delivering our continued commitment to quality to many more patients in the Middle East in the coming years. ”

Luca Lastrucci, Group CEO in Menarini, commented:Today’s inauguration of our MEA headquarters in Dubai is an important milestone for our company as we expand our investments in the MEA region. Our presence in a leading pharmaceutical center such as Dubai will strengthen Menarini’s opportunities and market access for breakthrough products in the field of cardiovascular diseases, gastrointestinal diseases and inflammatory diseases“. Lastrucci added: With a solid commercial infrastructure and impressive facilities, the United Arab Emirates government has shown continued support for investment in the pharmaceutical business. We see this as an important step in the right direction for Menarini and will continue to work with the UAE government to improve health standards and support the well-being of communities in the UAE and beyond.

dr Ali Al SayedDirector of the Department of Pharmaceutical Services at the Health Board Dubaicommented on the new regional premiere of Menarini, which fits perfectly into the industrial strategy of 2030 Dubai he agreed, saying: A key goal of Dubai’s strategy 2030 this to become a global hub for knowledge-based, sustainable and innovation-oriented enterprises. Menarini is a company with long roots in medical research and will therefore make an important contribution to this visionary strategy. Together, we share Dubai’s overarching vision for healthcare, Dubai position ourselves as a leading target for knowledge, education and training in the healthcare sector“.

The new headquarters of Menarini in DubaiWith a presence in 140 countries and more than 17,000 employees, it will be guided by Menarini’s deeply ingrained values: patient focus, focus on people and a commitment to quality, integrity and responsibility. This important milestone is a testament to Menarini’s relentless mission to treat disease on a global scale and put patient health above all else.

Information about Menarini

The Menarini Group is a leading international pharmaceutical and diagnostic company with sales of more than $ 4 billion and more than 17,000 employees. Menarini focuses on therapeutic areas with high unmet needs, offering products in the fields of cardiology, oncology, pulmonology, gastroenterology, infectious diseases, diabetology, inflammation and analgesia. With 18 production sites and 9 R&D centers, Menarini products are available in 140 countries around the world. For more information please

Picture –

Picture –

Logo –

Basel Taher (Menarini Regional Head for the Middle East and CEO of MEA), Luca Lastrucci (CEO of Menarini Group), Marwan Abdulaziz Janahi (Managing Director of Dubai Science Park), Nicola Lener (Italian Ambassador to the United Arab Emirates), Ugur Bingol (Menarini President of META) and Vito de Bellis (Regional Director of Menarini Africa) at the inauguration of the Menarini Regional Headquarters in DubaiLogo of the Menarini Group

Leave a Comment